ASO Visual Abstract: Neoadjuvant Dual Targeted HER2 Therapy and Neoadjuvant Chemo-Immunotherapy Is Associated with Improved Nodal pCR and Reduced Axillary Surgery
Saranya Prathibha, Tanya L. Hoskin, Matthew P. Goetz, Judy C. Boughey
Springer Nature ·
2026-09-28
· DOI 10.1245/s10434-026-20661-w
The publisher did not provide an abstract — full text is available via the link below.
Saranya Prathibha, Tanya L. Hoskin, Matthew P. Goetz, Judy C. Boughey. ASO Visual Abstract: Neoadjuvant Dual Targeted HER2 Therapy and Neoadjuvant Chemo-Immunotherapy Is Associated with Improved Nodal pCR and Reduced Axillary Surgery. // Annals of Surgical Oncology. – 2026. – DOI: 10.1245/s10434-026-20661-w. – URL: https://doi.org/10.1245/s10434-026-20661-w
Saranya Prathibha, Tanya L. Hoskin, Matthew P. Goetz, & Judy C. Boughey (2026). ASO Visual Abstract: Neoadjuvant Dual Targeted HER2 Therapy and Neoadjuvant Chemo-Immunotherapy Is Associated with Improved Nodal pCR and Reduced Axillary Surgery. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-026-20661-w
Saranya Prathibha, et al. “ASO Visual Abstract: Neoadjuvant Dual Targeted HER2 Therapy and Neoadjuvant Chemo-Immunotherapy Is Associated with Improved Nodal pCR and Reduced Axillary Surgery.” Annals of Surgical Oncology, 2026. doi:10.1245/s10434-026-20661-w.
@article{Prathibha2026,
title = {ASO Visual Abstract: Neoadjuvant Dual Targeted HER2 Therapy and Neoadjuvant Chemo-Immunotherapy Is Associated with Improved Nodal pCR and Reduced Axillary Surgery},
author = {Prathibha, Saranya and Hoskin, Tanya L. and Goetz, Matthew P. and Boughey, Judy C.},
journal = {Annals of Surgical Oncology},
year = {2026},
doi = {10.1245/s10434-026-20661-w},
url = {https://doi.org/10.1245/s10434-026-20661-w}
}